Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen, Copenhagen, Denmark; Secció de Zoologia i Antropologia Biòlogica, Departament de Biologia Evolutiva, Ecologia i Ciències Ambientals, Facultat de Biologia, Universitat de Barcelona, Barcelona, Spain.
Secció de Zoologia i Antropologia Biòlogica, Departament de Biologia Evolutiva, Ecologia i Ciències Ambientals, Facultat de Biologia, Universitat de Barcelona, Barcelona, Spain; Institut de Biomedicina de la Universitat de Barcelona, Barcelona, Spain.
J Gastrointest Surg. 2024 Sep;28(9):1400-1405. doi: 10.1016/j.gassur.2024.05.029. Epub 2024 May 29.
BACKGROUND: Bariatric surgery (BS) is currently the most effective long-term treatment of severe obesity. However, the interindividual variability observed in surgical outcomes suggests a moderating effect of several factors, including individual genetic background. This study aimed to investigate the contribution of the genetic architecture of body mass index (BMI) to the variability in weight loss outcomes after BS. METHODS: A total of 106 patients with severe obesity who underwent Roux-en-Y gastric bypass (RYGB) or sleeve gastrectomy were followed up for 5 years. Changes in BMI (BMIchange) and percentage of total weight loss (%TWL) were evaluated during the postoperative period. Polygenic risk scores (PRSs), including 50 genetic variants, were calculated for each participant to determine their genetic risk of high BMI based on a previous genome-wide association study. Generalized estimating equation models were used to study the role of the individual's polygenic score and other factors on BMIchange and %TWL in the long term after surgery. RESULTS: This study found an effect of the polygenic score on %TWL and BMIchange, in which patients with lower scores had better outcomes after surgery than those with higher scores. Furthermore, when analyzing only patients who underwent RYGB, the results were replicated, showing greater weight loss after surgery for patients with lower polygenic scores. DISCUSSION: Our results indicate that genetic background assessed with PRSs, along with other individual factors, such as biological sex, age, and preoperative BMI, has an effect on BS outcomes and could represent a useful tool for estimating surgical outcomes in advance.
背景:减重手术(BS)是目前治疗严重肥胖症最有效的长期治疗方法。然而,手术结果中观察到的个体间变异性表明,包括个体遗传背景在内的几个因素存在调节作用。本研究旨在探讨体重指数(BMI)遗传结构对 BS 后体重减轻结果变异性的贡献。
方法:共纳入 106 例接受 Roux-en-Y 胃旁路术(RYGB)或袖状胃切除术的严重肥胖患者,术后随访 5 年。在术后期间评估 BMI 变化(BMIchange)和总体重减轻百分比(%TWL)。为每个参与者计算多基因风险评分(PRSs),包括 50 个遗传变异,以根据先前的全基因组关联研究确定其高 BMI 的遗传风险。使用广义估计方程模型研究个体多基因评分和其他因素对手术后长期 BMIchange 和 %TWL 的作用。
结果:本研究发现多基因评分对%TWL 和 BMIchange 有影响,评分较低的患者手术后结果优于评分较高的患者。此外,仅分析接受 RYGB 的患者时,结果得到了复制,显示出较低多基因评分的患者手术后体重减轻更多。
讨论:我们的结果表明,用 PRSs 评估的遗传背景以及其他个体因素,如性别、年龄和术前 BMI,对 BS 结果有影响,可能是预测手术结果的有用工具。
J Gastrointest Surg. 2024-9
Surg Obes Relat Dis. 2018-3-26
Obes Facts. 2019-8-15
Surg Obes Relat Dis. 2021-1
J Am Coll Surg. 2024-6-1